- * Cidofovir Eye Drops
Because Cidofovir drops only require twice daily dosing, it offers a clear advantage over other topical antiviral eye drops that need to be applied much more often.
- * Famciclovir
Famciclovir is currently thought to be the most effective and safest medication for the treatment of a Feline Herpesvirus-1 breakout, especially in a cattery situation. Learn the proper dosage and dosing protocol for this once-a-day medication . . .
- * Feline Herpesvirus
Feline Herpesvirus is the most severe of the common upper respiratory viruses. Understanding how to combat this virus is an essential tool in every cattery`s management practices.
- * Feline Herpesvirus-1 Carrier Cats
Once your cattery has experienced a feline herpesvirus infection, virtually all of the infected cats will now be carriers of the virus. A "carrier" cat represents a possible future source of the infection because it can have a relapse and begin shedding the virus at any time. Learn more . . .
- * Herpes and Your Cat`s Eyes
Eye problems which can cause conjunctivitis, ulceration of the cornea, and potentially blindness are also a common symptom of feline herpes.
- * Interferon
The use of interferon in veterinary medicine is expanding as a treatment for FeLv, FIP, FIV and more...
- * L-Lysine
While L-lysine supplements will not prevent Feline Herpes Virus, conjunctivitis or upper respiratory infections, they may reduce the symptoms and speed recovery. Learn more about L-lysine . . .
- * Ten Ways To Minimize Feline Herpesvirus Outbreaks in Your Cattery
FHV-1 infections can be a major problem in breeding catteries, most often affecting young kittens between 4 to 8 weeks of age when the immunity they received from their mother wanes but before they receive their first vaccination. This article details the specific steps to take to prevent flare-ups of FHV-1 in your cattery . . .
- * Trifluridine Eye Drops
Trifluridine antiviral eye drops are used in the treatment of eye conditions caused by feline herpesvirus-1 infections. Learn more . . .